Allergan seeks deal with Salix to fend off Valeant - WSJ
August 19, 2014 at 14:02 PM EDT
Aug 19 (Reuters) - Botox maker Allergan Inc has approached Salix Pharmaceuticals Ltd and at least one other company about a potential takeover in a bid to avert the $53 billion hostile takeover from Valeant Pharmaceuticals International Inc, the Wall Street Journal said.
